QED Bioscience negotiated a deal to distribute Genovis’ antibody-engineering tools in the U.S. and through its distributors in Europe and Asia. The agreement follows from Genovis’ distribution deal for its transfection, RNAi, imaging, and antibody-engineering products with Bulldog Bio in September. Agreements in other territories are already in place, and in the U.S., Genovis also distributes its products through its own subsidiary.

Sweden-based Genovis is focused on developing technologies for cellular research. Based on its novel nano-induced magnetic transfer (NIMT®) platform, the company currently offers products in the areas of DNA transfection, siRNA delivery, cell labeling, and antibody fragmentation.

Previous articleBIO-Europe 2009 Day 2
Next articleOpening Up the Lines of Communication at the Patent Office